Literature DB >> 17071303

Perceptual voice analysis of patients with subglottic stenosis.

Sandra L Ettema1, Carol Jorgensen Tolejano, Robert J Thielke, Robert J Toohill, Albert L Merati.   

Abstract

OBJECTIVES: To characterize the perceptual assessment of vocal quality in subglottic stenosis (SGS) patients and to identify risk factors for dysphonia. STUDY DESIGN AND
SETTING: Retrospective review, academic center.
METHODS: Perceptual voice assessment using GRBAS scale (Grade, Roughness, Breathiness, Asthenia, Strain); patient characteristics determined for 31 SGS cases.
RESULTS: The mean GRBAS (0 to 3 scale, 0 = normal quality) for SGS patients at their initial visit was G(1.4)R(1.2)B(0.5)A(0.5)S(1.1). For males vs females: G(2.1 vs 1.1)R(2.0 vs 0.8)B(1.0 vs 0.4)A(1.0 vs 0.3)S(1.7 vs 0.9). The Grade (P < 0.03), Breathiness (P < 0.04), and Asthenia (P < 0.02) assessments were significantly more dysphonic in patients with multilevel stenosis; vocal fold motion impairment (VFMI) also impacted overall Grade (P < 0.01). Overall Grade (P < 0.002), Roughness (P < 0.007), and Breathiness (P < 0.006) were significantly worse in patients with prior airway surgery.
CONCLUSION: SGS patients demonstrate a mild to moderate change in perceptual voice characteristics with males in this series being more affected than females. Negative risk factors include multiple stenoses, VFMI, and previous airway surgery. SIGNIFICANCE: This is the first systematic report of perceptual voice assessment in subglottic stenosis. SGS patients have notable degrees of dysphonia with identifiable risk factors.

Entities:  

Mesh:

Year:  2006        PMID: 17071303     DOI: 10.1016/j.otohns.2006.06.1249

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  Effects of voice-sparing cricotracheal resection on phonation in women.

Authors:  Kristine Tanner; Christopher Dromey; Mark L Berardi; Lisa M Mattei; Jenny L Pierce; Jonathan J Wisco; Eric J Hunter; Marshall E Smith
Journal:  Laryngoscope       Date:  2016-11-24       Impact factor: 3.325

2.  Evaluation of Dyspnea Outcomes After Endoscopic Airway Surgery for Laryngotracheal Stenosis.

Authors:  Idris Samad; Lee Akst; Selmin Karatayli-Özgürsoy; Kristine Teets; Marissa Simpson; Ashwyn Sharma; Simon R A Best; Alexander T Hillel
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-11-01       Impact factor: 6.223

3.  Influence of subglottic stenosis on the flow-induced vibration of a computational vocal fold model.

Authors:  Simeon L Smith; Scott L Thomson
Journal:  J Fluids Struct       Date:  2013-01-24       Impact factor: 2.917

4.  Disease homogeneity and treatment heterogeneity in idiopathic subglottic stenosis.

Authors:  Alexander Gelbard; Donald T Donovan; Julina Ongkasuwan; S A R Nouraei; Guri Sandhu; Michael S Benninger; Paul C Bryson; Robert R Lorenz; William S Tierney; Alexander T Hillel; Shekhar K Gadkaree; David G Lott; Eric S Edell; Dale C Ekbom; Jan L Kasperbauer; Fabien Maldonado; Joshua S Schindler; Marshall E Smith; James J Daniero; C Gaelyn Garrett; James L Netterville; Otis B Rickman; Robert J Sinard; Christopher T Wootten; David O Francis
Journal:  Laryngoscope       Date:  2015-11-04       Impact factor: 3.325

5.  Prevalence and incidence of idiopathic subglottic stenosis in southern and central Alberta: a retrospective cohort study.

Authors:  Ryan K Chan; Beau Ahrens; Paul MacEachern; J Douglas Bosch; Derrick R Randall
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-11-12

6.  Treatment options in idiopathic subglottic stenosis: protocol for a prospective international multicentre pragmatic trial.

Authors:  Alexander Gelbard; Yu Shyr; Lynne Berry; Alexander T Hillel; Dale C Ekbom; Eric S Edell; Jan L Kasperbauer; David G Lott; Donald T Donovan; C Gaelyn Garrett; Guri Sandhu; James J Daniero; James L Netterville; Josh S Schindler; Marshall E Smith; Paul C Bryson; Robert R Lorenz; David O Francis
Journal:  BMJ Open       Date:  2018-04-10       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.